Medicare will pay for COVID-19
antibody infusions
|
Many providers
and suppliers will be able to bill Medicare to deliver antibody therapies to
treat COVID-19, as the FDA approved emergency use of one treatment. |
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment